MedTrace Logo

Topical Nitric Oxide Trial in Chronic Non-Healing Wounds

NCT00823095 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2016-02-26

Study results available
· View outcomes & findings →

Summary

To determine the effects of topically applied ViaNOx-H for 8 hours daily for 2 weeks on the reduction of the bio-burden in biofilms on chronic non-healing wounds as recorded by measurements of wound size and wound culture.

Conditions

  • Chronic Ulcer of Lower Extremity

Interventions

DRUG

Nitric Oxide

Topically applied gaseous nitric oxide at 8 to 10 parts per million, for 8 hours each night for 14 nights.

Sponsors & Collaborators

  • Nitric BioTherapeutics, Inc

    collaborator INDUSTRY

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Takkin Lo, MD, MPH · Loma Linda University Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2008-10-31
Completion
2008-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00823095 on ClinicalTrials.gov